IMAGING SHARED RESOURCE
IMAGING SHARED RESOURCE
批准号:
8689269
负责人:
Dario C Altieri
金额:
$7.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-03-01 至 2019-02-28
关键词:
AnimalsBasic Cancer ResearchBehaviorBiological AssayCancer CenterCancer Research ProjectCellsClassificationCollaborationsComplexComputer softwareConsultCustomDataDevelopmentDiagnosisDiseaseEquipmentEthicsEventExperimental DesignsFlow CytometryFundingGoalsGrantImageImage AnalysisImaging TechniquesInstitutesInstructionLasersLeadershipLifeMalignant - descriptorMicroscopeMicroscopyMissionNatureOrganismPathogenesisPhotobleachingPhotographyPublicationsResearch PersonnelResolutionResource SharingResourcesScanningServicesStressTechniquesTechnologyTherapeutic AgentsTimeTissuesTrainingWorkanimal resourceexperienceimaging modalityimprovedmemberprogramsresearch studytherapy resistanttwo-photonwhole body imaging
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Imaging Shared Resource provides Wistar Institute Cancer Center members access to high end
microscopy and small animal imaging services. In recent years, technological advances have made it
possible to utilize quantitative, high resolution imaging approaches to dissect spatio-temporal requirements
of cellular behavior related to malignant transformation, metastatic dissemination and resistance to therapy.
During the last project period of this application, this Resource has undergone a major transformation with
new scientific leadership and a significant expansion of the technologic capabilities needed to support a
broad array of experimental imaging. The Imaging Resource now offers widefield, upright and inverted
microscopy, low magnification imaging, close-up and macro photography, live-cell time lapse imaging, laser
scanning confocal imaging, 2-photon microscopy, and small animal whole body imaging.
During the last funding period the Cancer Center has made a significant effort to upgrade the Resource,
investing over $0.6 million to create a new confocal suite equipped with a Leica TCS SP5 II scanning laser
confocal microscope. Highly experienced staff are available to consult with investigators on experimental
design, imaging techniques, and post-acquisition analysis to provide optimal results from equipment and
techniques. Staff members work directly with users to acquire their images, or train users to operate the
equipment independently. Other services include developing custom image analysis macros, assistance
with maintaining imaging equipment and assistance and training with image editing software for publication.
The Resource also carries out technically complex photobleaching assay experiments, and 3D and 4D
tracking. The Resource stresses ethical practices in image manipulation, as well as in all aspects of image
acquisition, adjustment and analysis. The Resource actively collaborates with other Cancer Center Shared
Resources to assist users with high-throughput imaging modalities available in those Resources, including,
for example, the Amnis ImageStream in collaboration with the Flow Cytometry Resource, and the IVIS 2001
small animal imager in collaboration with the Animal Resource. Imaging was classified as a Type I Shared
Resource to reflect the well-defined, essential nature of its services. This classification is described in the
Cancer Center Administration section of this application. During the past project period. Cancer Center
members from all three Programs have leveraged the services of the Resource and generated critical
preliminary data that considerably increased the priority of scientific publications and grant submissions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Augmenting T-cell immunotherapy outcomes in blood and solid tumor microenvironment in ART-suppressed HIV infection (immune/microenvironment)
-
批准号:10620011
-
项目类别:
-
资助金额:$12.42万
-
财政年份:2022
-
负责人:Dario C Altieri
-
依托单位:
A First-in-Human Phase I Clinical Trial of Mitochondrial-Targeted Hsp90 Inhibitor, Gamitrinib
-
批准号:10472429
-
项目类别:
-
资助金额:$31.63万
-
财政年份:2021
-
负责人:Dario C Altieri
-
依托单位:
A First-in-Human Phase I Clinical Trial of Mitochondrial-Targeted Hsp90 Inhibitor, Gamitrinib
-
批准号:9668658
-
项目类别:
-
资助金额:$41.03万
-
财政年份:2021
-
负责人:Dario C Altieri
-
依托单位:
Tumor Plasticity
-
批准号:10474434
-
项目类别:
-
资助金额:$111.72万
-
财政年份:2017
-
负责人:Dario C Altieri
-
依托单位:
Tumor Plasticity
-
批准号:10248385
-
项目类别:
-
资助金额:$114.0万
-
财政年份:2017
-
负责人:Dario C Altieri
-
依托单位:
Tumor Plasticity
-
批准号:9767084
-
项目类别:
-
资助金额:$110.42万
-
财政年份:2017
-
负责人:Dario C Altieri
-
依托单位:
Tumor Plasticity
-
批准号:10684678
-
项目类别:
-
资助金额:$111.72万
-
财政年份:2017
-
负责人:Dario C Altieri
-
依托单位:
Tumor Plasticity
-
批准号:9538612
-
项目类别:
-
资助金额:$114.0万
-
财政年份:2017
-
负责人:Dario C Altieri
-
依托单位:
Molecular and Cellular Oncogenesis
-
批准号:8690263
-
项目类别:
-
资助金额:$3.77万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Planning and Evaluation
-
批准号:8690274
-
项目类别:
-
资助金额:$3.53万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
(PQC2) Plasticity Of The.PI3K Network In Early Dormancy
-
批准号:8791730
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Bioinformatics Shared Resources
-
批准号:8690292
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Genomics
-
批准号:8932921
-
项目类别:
-
资助金额:$21.48万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Gene Expression
-
批准号:8689270
-
项目类别:
-
资助金额:$4.18万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Developmental Funds
-
批准号:8690275
-
项目类别:
-
资助金额:$44.68万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Proteomics Shared Resource
-
批准号:8932923
-
项目类别:
-
资助金额:$18.74万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Animal Facility Shared Resources
-
批准号:8690265
-
项目类别:
-
资助金额:$25.87万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Molecular Screening Shared Resource
-
批准号:8932922
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
(PQC2) Plasticity Of The.PI3K Network In Early Dormancy
-
批准号:9112948
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
Senior Leadership
-
批准号:8690273
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2014
-
负责人:Dario C Altieri
-
依托单位:
海外基金